Tower Research Capital LLC (TRC) - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 46 filers reported holding REGULUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$8,000
+300.0%
28,441
+315.7%
0.00%
Q4 2021$2,000
-97.3%
6,841
-92.6%
0.00%
-100.0%
Q2 2021$75,000
+7.1%
91,872
+105.0%
0.00%
+100.0%
Q1 2021$70,000
-57.1%
44,806
-63.0%
0.00%
-80.0%
Q4 2020$163,000
+1064.3%
120,986
+353.0%
0.01%
Q3 2020$14,000
-53.3%
26,707
-39.6%
0.00%
-100.0%
Q2 2020$30,00044,186
+21993.0%
0.00%
Q2 2019$0
-100.0%
200
-82.6%
0.00%
Q1 2019$1,000
-75.0%
1,149
-73.5%
0.00%
Q4 2018$4,0004,3380.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,851,851$951,0000.11%
BVF INC/IL 3,217,480$1,654,0000.09%
NEA Management Company, LLC 2,052,455$1,055,0000.04%
McGuire Investment Group, LLC 24,000$12,0000.00%
WEDBUSH SECURITIES INC 70,204$36,0000.00%
GRIMES & COMPANY, INC. 23,998$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,200$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 64,347$33,0000.00%
MILLENNIUM MANAGEMENT LLC 49,497$25,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders